- Home
- RMMZ vs ORMP Comparison
RMMZ vs ORMP Comparison
Compare RMMZ & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RMMZ | ORMP |
|---|---|---|
| Founded | 2022 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 123.9M | 117.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | RMMZ | ORMP |
|---|---|---|
| Price | $14.52 | $2.87 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 25.6K | ★ 165.3K |
| Earning Date | 01-01-0001 | 11-13-2025 |
| Dividend Yield | ★ 7.33% | N/A |
| EPS Growth | N/A | ★ 838.25 |
| EPS | 0.82 | ★ 1.03 |
| Revenue | N/A | ★ $2,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $19.41 | ★ $2.74 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.92 | $1.82 |
| 52 Week High | $16.99 | $3.24 |
Technical Indicators
Market Signals| Indicator | RMMZ | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 40.94 | 51.68 |
| Support Level | $14.65 | $2.83 |
| Resistance Level | $14.83 | $3.24 |
| Average True Range (ATR) | 0.23 | 0.16 |
| MACD | -0.03 | -0.03 |
| Stochastic Oscillator | 21.69 | 23.34 |
Price Performance
Historical ComparisonAbout RMMZ RiverNorth Managed Duration Municipal Income Fund II Inc.
RiverNorth Managed Duration Municipal Income Fund II Inc is a diversified, closed-end management investment company. The Fund's primary investment objective is current income exempt from regular U.S. federal income taxes. The Fund's secondary investment objective is total return.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.